Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sopheon extend innovation leadership with Simplot

28 Jan 2021 07:00

RNS Number : 1101N
Sopheon PLC
28 January 2021
 

SOPHEON PLC

("Sopheon" or the "Company")

 

Sopheon and Australian Partner Prodex Systems Extend CPG Innovation Leadership with the J. R. Simplot Company Contract

 

Sopheon and Prodex Systems team up to enable innovation governance and portfolio prioritization for the global food and agribusiness firm

 

Sopheon, an international global leader in enterprise innovation management solutions, and its consulting partner Prodex Systems Australasia will automate and accelerate innovation at the J. R. Simplot Company, the global food and agribusiness firm. Sopheon and Prodex will collaborate to deploy Sopheon's Accolade® platform at Simplot, beginning with its Simplot Australia division. The goal of Simplot's deployment is to reduce innovation risk and increase the likelihood of new product successes via the adoption of Sopheon Stage-Gate® best practices.

 

According to Angeline Achariya, Executive Director of Innovation & Growth at Simplot Australia Proprietary Ltd., "At Simplot, we are committed to a strategy to accelerate growth in EBIT through significant increases in contribution from New Product Introductions. Simplot undertook a rigorous search for the appropriate software platform and partner to support ambitious growth goals."

 

The first phase of deployment will provide full enterprise capabilities in innovation governance. Simplot selected Sopheon's software platform for its advanced capabilities in innovation planning and roadmapping, and the ability to align targeted ideation campaigns with strategic planning gaps. These foundational capabilities will streamline Simplot's innovation processes and drive the adoption of scalable, enterprise-wide process standards, improving efficiency, time to market, and portfolio success.

 

Sopheon CEO, Andy Michuda, added: "We are excited to include Simplot in our growing Sopheon family of food and agribusiness clients, and are delighted to team with our long-time partner Prodex to enable Simplot's global innovation transformation. This contract aligns well with Sopheon's objective to expand our user base in the Australasian region."

 

Prodex Systems Managing Director, Gerard Ryan, added: "Prodex has been a supplier to Simplot Australia for over 10 years. Sopheon has deep domain expertise, and a great depth of configurability in the Accolade software, a common requirement of large, global consumer goods firms. We look forward to growing our partnership with Simplot, and to helping them achieve their impressive growth goals for many years to come."

 

 

For further information contact:

Barry Mence (Chairman)Arif Karimjee (CFO)

Sopheon plc

+ 44 (0) 1276 919 560

Carl Holmes/Giles Rolls (Corporate Finance)Alice Lane/Sunila da Silva (ECM)

finnCap Ltd

+ 44 (0) 20 7220 0500

 

Sopheon and Accolade are trademarks of Sopheon plc. Stage-Gate® is a registered trademark of Stage-Gate Inc.

About Sopheon. Sopheon (LSE: SPE) partners with customers to provide complete enterprise innovation management solutions including software, expertise, and best practices, that enable them to achieve exceptional long-term revenue growth and profitability. Sopheon's Accolade solution provides unique, fully-integrated coverage for the entire innovation management and new product development lifecycle, including strategic innovation planning, roadmapping, idea and concept development, process and project management, portfolio management and resource planning. Sopheon's solutions have been implemented by over 200 customers with over 60,000 users in over 50 countries. Sopheon is listed on AIM, operated by the London Stock Exchange. For more information, please visit www.sopheon.com.

 

About Prodex Systems Australasia. Prodex Systems is a specialist provider of innovation consulting, training and software services implementation which facilitate best-practice management of new product development through Systematic Innovation Governance in Australia, New Zealand and South East Asia. Our consulting assignments include the implementation of Stage-Gate® and Product Portfolio Management systems and are supported by our capabilities for in-house training. Prodex Systems is the Australasian reseller and consulting support partner for Sopheon's Accolade solution for Enterprise Innovation Management. For more information, please visit www.prodex.com.au.

 

About Simplot. The J. R. Simplot Company, is a privately held food and agriculture company headquartered in Boise, Idaho, with an integrated portfolio that includes phosphate mining, fertilizer manufacturing, farming, ranching and cattle production, food processing, food brands, and other enterprises. Simplot's major operations are located in the U.S., Canada, Mexico, Australia, Argentina and China, with products marketed in more than 100 countries worldwide. For more information, visit www.simplot.com.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABRMFTMTTTBIB
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.